Liraglutide CAS NO.204656-20-2

Liraglutide Basic information

Product Name:    Liraglutide
Synonyms:    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
CAS:    204656-20-2
MF:    C172H265N43O51
MW:    3751.202
EINECS:    810-818-7
Product Categories:    
Mol File:    204656-20-2.mol

Liraglutide Chemical Properties
Melting point     >182°C (dec.)
storage temp.     Refrigerator
solubility     DMSO (Slightly), Water (Slightly)
form     Solid
color     White to Off-White

Safety Information
Hazardous Substances Data    204656-20-2(Hazardous Substances Data)

Originator    Massachusetts General Hospital (US)
Uses    Liraglutide activates AMP-activated protein kinase thus enhancing insulin sensitivity.
Definition    ChEBI: A lipopeptide that is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. Used as an adjunct to diet and exercise to improve gly emic control in adults with type 2 diabetes mellitus.